Effect of piroxicam gel for pain control and inflammation in Nd:YAG 1064-nm laser hair removal

Journal of the European Academy of Dermatology and Venereology

Volumn 21, Issue 3, 2007, Pages 380-383

  Akinturk, S ^b   Eroglu, A ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^b Bati Bahat Hospital   (Turkey)

Author keywords

Hair removal; Nd:YAG laser; Piroxicam gel

Indexed keywords

PIROXICAM; PLACEBO;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ERYTHEMA; ESTHETIC SURGERY; FEMALE; FOLLICULITIS; HUMAN; MAJOR CLINICAL STUDY; NEODYMIUM LASER; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN EDEMA; SKIN INFLAMMATION; SKIN PAIN; TOPICAL ANESTHESIA; VISUAL ANALOG SCALE;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHI-SQUARE DISTRIBUTION; FEMALE; GELS; HAIR REMOVAL; HUMANS; INFLAMMATION; LASERS; PAIN; PAIN MEASUREMENT; PIROXICAM; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 33846993025     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01979.x     Document Type: Article

References (16)

1. Friedman P, Fogelman J, Nouri K et al. Comparative study of the efficacy of four topical anesthetics. Dermatol Surg 1999; 25: 950-954.
2. Guardiano RA, Norwood CW. Direct comparison of EMLA versus lidocaine for pain control in Nd:YAG 1064 nm laser hair removal. Dermatol Surg 2005; 31: 396-398.
3. Friedman P, Mafong E, Friedman E et al. Topical anesthetics update: EMLA and beyond. Dermatol Surg 2001; 27: 1019-1026.
4. Hahn IH, Hoffman RS, Nelson LS. EMLA-induced methemoglobinemia and systemic topical anesthetic toxicity. J Emerg Med 2004; 26: 85-88.
5. Lorenz S, Brunnberg S, Landthaler M, Hohenleutner U. Hair removal with the Aong pulsed Nd:YAG laser: aprospective study with one year follow-up. Lasers Surg Med 2002; 30: 127-134.
6. Moore RA, Tramer MR, Carroll D, Wiffen PJ, McQuary HJ. Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. Br Med J 1998; 316: 333-338.
7. O'Hanlon JJ, McCleane G, Muldoon T. Preoperative application of piroxicam gel compared to a local anaesthetic field block for postoperative analgesia. Acta Anaesthesiol Scand 1996; 40: 715-718.
8. Dutta A, Puri GD, Wig J. Piroxicam gel, compared to EMLA cream is associated with less pain after venous cannulation in volunteers. Can J Anesth 2003; 50: 775-778.
9. Dawson-Saunders B, Trapp RG. Basis and Clinical Biostatistics, 2nd edn. Appleton & Lange, East Norwalk, CT, 1994: 119-124.
10. Galadari I. Comparative evaluation of different hair removal lasers in skin types IV, V, VI. Int J Dermatol 2003; 42: 68-73.
11. Altman DA, Gildenberg SR. High-energy pulsed light source hair removal device used to evaluate the onset of action of a new topical anesthetic. Dermatol Surg 1999; 10: 816-818.
12. van Haselen RA, Fisher PAG. A randomized controlled trial comparing topical piroxicam gel with a homeopathic gel in osteoarthritis of the knee. Rheumatology 2000; 39: 714-719.
13. Battle EF, Hobbs LM. Laser-assisted hair removal for darker skin types. Dermatol Ther 2004; 17: 177-183.
14. Landthaler M, Haina D, Brunner R, Waidelich W, Braun-Falco O. Effects of argon, dye and Nd:YAG lasers on epidermis, dermis and venous vessels. Lasers Surg Med 1986; 6: 87-93.
15. Cotsarelis G, Sun TT, Lavker RM. Label-retaining cells reside in the bulge area of pilosebaceous unit: Implication for follicular stem cells, hair cycle and skin carcinogemesis. Cell 1990; 61: 1329-1337.
16. Alster T, Bryan H, Williams CM. Long pulsed Nd:YAG laser assisted hair removal in pigmented skin. Arch Dermatol 2001; 137: 885-889.